Multivariable logistic regression models for successful cardioversion after electrical cardioversion
| OR (95% CI)* | |
| Women | |
| Age | 1.06 (0.83 to 1.35) |
| Atrial diameter | 0.85 (0.67 to 1.08) |
| Thyroid-stimulating hormone, IU/L | 1.23 (0.96 to 1.58) |
| Beta-blockers | 0.64 (0.36 to 1.15) |
| Diabetes mellitus | 0.49 (0.20 to 1.22) |
| Men | |
| Age | 1.05 (0.90 to 1.22) |
| Left atrial diameter | 0.74 (0.63 to 0.87) |
| LVEF <40% (vs ≥40 %) | 1.46 (1.02 to 2.08) |
| ACEI or ARB | 0.72 (0.53 to 0.97) |
Among women, 300 of 332 (90.4%) patients were complete cases, and among men, 717 of 790 (90.8%) patients were complete cases.
*ORs associated with 1 SD increase were reported. SD for women: age 9.91; atrial diameter 0.56; thyroid-stimulating hormone 1.93. SD for men: age 10.12; atrial diameter 0.57.
ACEI, ACE inhibitor; ARB, angiotensin II receptor blocker; LVEF, left ventricular ejection fraction.